Next Article in Journal
Evolution of CCR5 and CCR2 Genes in Bats Showed Multiple Independent Gene Conversion Events
Next Article in Special Issue
One-Enzyme RTX-PCR for the Detection of RNA Viruses from Multiple Virus Genera and Crop Plants
Previous Article in Journal
Molecular Epidemiology of Norovirus (NoV) Infection in Mie Prefecture: The Kinetics of Norovirus Antigenemia in Pediatric Patients
Previous Article in Special Issue
Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein
 
 
Review

Targeting the Virus Capsid as a Tool to Fight RNA Viruses

Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague, Czech Republic
*
Author to whom correspondence should be addressed.
Academic Editor: Akira Ono
Viruses 2022, 14(2), 174; https://doi.org/10.3390/v14020174
Received: 20 December 2021 / Revised: 14 January 2022 / Accepted: 16 January 2022 / Published: 18 January 2022
Several strategies have been developed to fight viral infections, not only in humans but also in animals and plants. Some of them are based on the development of efficient vaccines, to target the virus by developed antibodies, others focus on finding antiviral compounds with activities that inhibit selected virus replication steps. Currently, there is an increasing number of antiviral drugs on the market; however, some have unpleasant side effects, are toxic to cells, or the viruses quickly develop resistance to them. As the current situation shows, the combination of multiple antiviral strategies or the combination of the use of various compounds within one strategy is very important. The most desirable are combinations of drugs that inhibit different steps in the virus life cycle. This is an important issue especially for RNA viruses, which replicate their genomes using error-prone RNA polymerases and rapidly develop mutants resistant to applied antiviral compounds. Here, we focus on compounds targeting viral structural capsid proteins, thereby inhibiting virus assembly or disassembly, virus binding to cellular receptors, or acting by inhibiting other virus replication mechanisms. This review is an update of existing papers on a similar topic, by focusing on the most recent advances in the rapidly evolving research of compounds targeting capsid proteins of RNA viruses. View Full-Text
Keywords: antivirals; virus inhibitor; antiviral compounds; capsid assembly; assembly inhibitor; capsid binding; capsid targeting antivirals; virus inhibitor; antiviral compounds; capsid assembly; assembly inhibitor; capsid binding; capsid targeting
MDPI and ACS Style

Hozáková, L.; Vokatá, B.; Ruml, T.; Ulbrich, P. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022, 14, 174. https://doi.org/10.3390/v14020174

AMA Style

Hozáková L, Vokatá B, Ruml T, Ulbrich P. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses. 2022; 14(2):174. https://doi.org/10.3390/v14020174

Chicago/Turabian Style

Hozáková, Lucie, Barbora Vokatá, Tomáš Ruml, and Pavel Ulbrich. 2022. "Targeting the Virus Capsid as a Tool to Fight RNA Viruses" Viruses 14, no. 2: 174. https://doi.org/10.3390/v14020174

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop